Concepedia

Apixaban for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: The PAROS cross-sectional study of routine clinical practice

Bruno Falissard, Fabien Picard, Isabelle Mahé, Olivier Hanon, Emmanuel Touzé, Nicolas Danchin, François-Xavier Lamy, Lea Ricci, Philippe Gabríel Steg

Archives of cardiovascular diseases · 2019 · 11 citations · 25 references

DOIFull text

Open access

Concepts

References

25

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.2K citations · Full text

, , +12

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text

, , +15

Apixaban versus Warfarin in Patients with Atrial Fibrillation

Christopher B. Granger, John H. Alexander, John J.V. McMurray et al. · New England Journal of Medicine · 2011 · 8.9K citations · Full text

, , +11

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

Gregory Y.H. Lip, Robby Nieuwlaat, Ron Pisters et al. · CHEST Journal · 2009 · 6.7K citations · Full text

, , +16

Validation of a combined comorbidity index

Mary E. Charlson, Ted P. Szatrowski, Janey C. Peterson et al. · Journal of Clinical Epidemiology · 1994 · 6.6K citations

, , +12